Page last updated: 2024-09-04

moxifloxacin and Lung Neoplasms

moxifloxacin has been researched along with Lung Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bian, S; Lei, W; Tang, X1
Chen, W; Cheng, NC; Fang, G; Hu, CM; Huang, LL; Xie, WP1
Bulcun, E; Çimen, D; Ekici, A; Ekici, M; Güngör, Ö1
Becker, J; Chatzikyrkou, C; Clajus, C; Hafer, C; Hamwi, I; Kielstein, JT1
Arvis, P; Breilh, D; Djabarouti, S; Gordien, JB; Jougon, J; Landreau, V; Saux, MC; Velly, JF; Xuereb, F1

Reviews

1 review(s) available for moxifloxacin and Lung Neoplasms

ArticleYear
The first report of co-existence of pulmonary tuberculosis and lung malignancy in a kidney transplant recipient: a case report and literature review.
    BMC infectious diseases, 2021, Jul-01, Volume: 21, Issue:1

    Topics: Adenocarcinoma; China; Ethambutol; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Isoniazid; Kidney Transplantation; Lung; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Thoracic Surgery, Video-Assisted; Treatment Outcome; Tuberculosis, Pulmonary

2021

Trials

1 trial(s) available for moxifloxacin and Lung Neoplasms

ArticleYear
Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
    Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:6

    Topics: Administration, Oral; Adult; Antibiotic Prophylaxis; Aza Compounds; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Infusions, Intravenous; Lung; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Postoperative Complications; Prospective Studies; Quinolines; Reference Values; Risk Factors; Tissue Distribution; Treatment Outcome

2003

Other Studies

3 other study(ies) available for moxifloxacin and Lung Neoplasms

ArticleYear
A case of torsades de pointes induced by the third-generation EGFR-TKI, osimertinib combined with moxifloxacin.
    BMC pulmonary medicine, 2020, Jun-24, Volume: 20, Issue:1

    Topics: Acrylamides; Aged, 80 and over; Aniline Compounds; Carcinoma, Non-Small-Cell Lung; Drug Therapy, Combination; ErbB Receptors; Humans; Lung Neoplasms; Male; Moxifloxacin; Mutation; Protein Kinase Inhibitors; Torsades de Pointes

2020
Case of round pneumonia: pulmonary infarct and a rare situation that is similar with the lung cancer.
    The clinical respiratory journal, 2015, Volume: 9, Issue:4

    Topics: Diagnosis, Differential; Fluoroquinolones; Humans; Levofloxacin; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Pneumonia; Pulmonary Infarction; Radiography, Thoracic; Treatment Outcome; Young Adult

2015
Biopsy proven acute interstitial nephritis after treatment with moxifloxacin.
    BMC nephrology, 2010, Aug-23, Volume: 11

    Topics: Acute Disease; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Biopsy; Carcinoma, Non-Small-Cell Lung; Creatinine; Edema; Eosinophilia; Fluoroquinolones; Humans; Lung Neoplasms; Male; Moxifloxacin; Nephritis, Interstitial; Pneumonectomy; Pneumonia; Postoperative Complications; Prednisolone; Quinolines

2010